Britannia Life Sciences (XCNQ:BLAB) ROCE % : -23.40% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Britannia Life Sciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Britannia Life Sciences's annualized ROCE % for the quarter that ended in Sep. 2024 was -23.40%.

Britannia Life Sciences ROCE % Historical Data

The historical data trend for Britannia Life Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Britannia Life Sciences ROCE % Chart

Britannia Life Sciences Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

ROCE %

6.74

-91.22

42.32

-20.72

Britannia Life Sciences Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial												27.98	15.03	-154.82	-14.27	-23.40

Britannia Life Sciences ROCE % Calculation

Britannia Life Sciences's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	-3.182	/	( ( (23.548 - 4.598)	+	(22.262 - 10.502) )	/ 2 )
	=	-3.182	/	( (18.95	+	11.76)	/ 2 )
	=	-3.182	/	15.355
	=	-20.72 %

Britannia Life Sciences's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-2.588	/	( ( (21.729 - 10.904)	+	(22.756 - 11.461) )	/ 2 )
	=	-2.588	/	( ( 10.825	+	11.295 )	/ 2 )
	=	-2.588	/	11.06
	=	-23.40 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Britannia Life Sciences (XCNQ:BLAB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Britannia Life Sciences ROCE % Related Terms

Thank you for viewing the detailed overview of Britannia Life Sciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Britannia Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Britannia Life Sciences Inc (XCNQ:BLAB) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1

Website

https://www.britannia.life

Britannia Life Sciences Inc provides product testing, safety assessment and compliance services to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally.

Executives

Peter James Shippen

10% Security Holder, Director, Senior Officer

Britannia Life Sciences Headlines

No Headlines